Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hartl

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|December 6, 1996
Development of potent thrombin receptor antagonist peptidesM S Bernatowicz, C E Klimas, K S Hartl, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1993
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor productionM C Kowala, C E Mazzucco, K S Hartl, et al.
Journal of Arrhythmia|January 27, 2025
Comparative analysis of left atrial size and appendage morphology in paroxysmal and persistent atrial fibrillation patientsJ Pongratz, L Riess, S Hartl, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Synthesis of potent and selective 2-azepanone inhibitors of human tryptaseGuohua Zhao, Scott A Bolton, Chet Kwon, et al.
Frontiers in Cardiovascular Medicine|July 5, 2023
Left atrial appendage volume is an independent predictor of atrial arrhythmia recurrence following cryoballoon pulmonary vein isolation in persistent atrial fibrillationJ Pongratz, L Riess, S Hartl, et al.
Journal of Lipid Mediators|June 1, 1993
Isolation and identification of lysophosphatidylcholines as endogenous modulators of thromboxane receptorsD W Phillipson, A A Tymiak, J G Tuttle, et al.
European Journal of Pharmacology|June 29, 2007
Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in ratsWilliam A Schumacher, Steven E Seiler, Thomas E Steinbacher, et al.
Respiratory Medicine|January 15, 2022
Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in AustriaH Abozid, C A Baxter, S Hartl, et al.
The European Respiratory Journal|June 23, 2009
Incidence and outcome of weaning from mechanical ventilation according to new categoriesG-C Funk, S Anders, M-K Breyer, et al.
Drug Design and Discovery|January 1, 1994
Non-prostanoid prostacyclin mimetics. 6. Derivatives of 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified beta-to the oxazole ringN A Meanwell, M J Rosenfeld, A K Trehan, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|December 6, 1996
Development of potent thrombin receptor antagonist peptidesM S Bernatowicz, C E Klimas, K S Hartl, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1993
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor productionM C Kowala, C E Mazzucco, K S Hartl, et al.
Journal of Arrhythmia|January 27, 2025
Comparative analysis of left atrial size and appendage morphology in paroxysmal and persistent atrial fibrillation patientsJ Pongratz, L Riess, S Hartl, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Synthesis of potent and selective 2-azepanone inhibitors of human tryptaseGuohua Zhao, Scott A Bolton, Chet Kwon, et al.
Frontiers in Cardiovascular Medicine|July 5, 2023
Left atrial appendage volume is an independent predictor of atrial arrhythmia recurrence following cryoballoon pulmonary vein isolation in persistent atrial fibrillationJ Pongratz, L Riess, S Hartl, et al.
Journal of Lipid Mediators|June 1, 1993
Isolation and identification of lysophosphatidylcholines as endogenous modulators of thromboxane receptorsD W Phillipson, A A Tymiak, J G Tuttle, et al.
European Journal of Pharmacology|June 29, 2007
Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in ratsWilliam A Schumacher, Steven E Seiler, Thomas E Steinbacher, et al.
Respiratory Medicine|January 15, 2022
Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in AustriaH Abozid, C A Baxter, S Hartl, et al.
The European Respiratory Journal|June 23, 2009
Incidence and outcome of weaning from mechanical ventilation according to new categoriesG-C Funk, S Anders, M-K Breyer, et al.
Drug Design and Discovery|January 1, 1994
Non-prostanoid prostacyclin mimetics. 6. Derivatives of 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified beta-to the oxazole ringN A Meanwell, M J Rosenfeld, A K Trehan, et al.
Pageof 4